Amanote Research
Register
Sign In
552. CRISPR/Cas9-Based Transcriptional Repressors for Control of Human Gene Expression
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)35565-4
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2014
Authors
Unknown
Publisher
Elsevier BV
Related search
Reversible RNA Acylation for Control of CRISPR-Cas9 Gene Editing
Chemical Science
Chemistry
CRISPR-Cas9 HDR System Enhances AQP1 Gene Expression
Oncotarget
Oncology
RNA-guided Gene Activation by CRISPR-Cas9–based Transcription Factors
Nature Methods
Biochemistry
Biotechnology
Cell Biology
Molecular Biology
CRISPR-Cas9 in Gene Therapy: Much Control on Breaking, Little Control on Repairing
Transcriptional Regulation With CRISPR-Cas9: Principles, Advances, and Applications
Current Opinion in Biotechnology
Bioengineering
Biomedical Engineering
Biotechnology
CRISPR-Cas9 in Gene Therapy: Much Control on Breaking, Little Control on Repairing
Integrate CRISPR/Cas9 for Protein Expression of HLA-B*38:68Q via Precise Gene Editing
Scientific Reports
Multidisciplinary
Transient Retrovirus-Based CRISPR/Cas9 All-In-One Particles for Efficient, Targeted Gene Knockout
Molecular Therapy - Nucleic Acids
Drug Discovery
Molecular Medicine
CRISPR/Cas9 Application for Gene Copy Fate Survey of Polyploid Vertebrates
Frontiers in Genetics
Genetics
Molecular Medicine
